Interferon Regulatory Factor 9 (IRF9) Peptid
IRF9
Reaktivität: Human
Wirt: Synthetic
BP, IHC, WB
-
- Target Alle IRF9 Produkte
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
- Spezies
- Human
- Quelle
- Synthetic
- Applikation
- Blocking Peptide (BP), Immunohistochemistry (IHC), Western Blotting (WB)
- Produktmerkmale
- This is a synthetic peptide designed for use in combination with anti-ISGF3G antibody (Catalog #: ARP31200_P050). It may block above mentioned antibody from binding to its target protein in western blot and/or immunohistochecmistry under proper experimental settings. There is no guarantee for its use in other applications.
- Aufreinigung
- Purified
-
- Applikationshinweise
- Each Investigator should determine their own optimal working dilution for specific applications.
- Beschränkungen
- Nur für Forschungszwecke einsetzbar
-
- Format
- Lyophilized
- Rekonstitution
- Add 100 μL of sterile PBS. Final peptide concentration is 1 mg/mL in PBS.
- Konzentration
- 1 mg/mL
- Buffer
- Final peptide concentration is 1 mg/mL in PBS.
- Handhabung
- Avoid repeated freeze-thaw cycles.
- Lagerung
- -20 °C
- Informationen zur Lagerung
- For longer periods of storage, store at -20°C. Avoid repeat freeze-thaw cycles.
-
- Target
- IRF9 (Interferon Regulatory Factor 9 (IRF9))
- Synonyme
- IRF-9 Peptide, ISGF3 Peptide, ISGF3G Peptide, p48 Peptide, zgc:92097 Peptide, Irf-9 Peptide, Isgf3g Peptide, interferon regulatory factor 9 Peptide, IRF9 Peptide, irf9 Peptide, Irf9 Peptide
- Hintergrund
-
ISGF3G functions to recruit RNA polymerase II to the promoter of interferon-stimulated genes and requires histone deacetylases. Defects in ISGF3 can cause resistance to IFN-.(2a) treatment.
Alias Symbols: IRF-9, ISGF3, ISGF3G, p48
Protein Interaction Partner: STAT2,IFNA1,STAT1,STAT2,NFKB1,RELA,STAT1,STAT2
Protein Size: 393 - Molekulargewicht
- 44 kDa
- Gen-ID
- 10379
- NCBI Accession
- NM_006084, NP_006075
- UniProt
- Q00978
-
Sie sind hier:
